Site specific effects of zoledronic acid during tibial and mandibular fracture repair

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yu, Yan Yiu ^a   Lieu, Shirley ^a   Hu, Diane ^a   Miclau, Theodore ^a   Colnot, Céline ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; DRUG EFFECT; ENCHONDRAL OSSIFICATION; FRACTURE FIXATION; FRACTURE HEALING; HYPERTROPHY; MALE; MANDIBLE FRACTURE; MOUSE; NONHUMAN; OSTEOCLAST; TIBIA FRACTURE; ANIMAL; BONE NECROSIS; C57BL MOUSE; CARTILAGE; COMPARATIVE STUDY; REGENERATION;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CARTILAGE; DIPHOSPHONATES; FRACTURE HEALING; IMIDAZOLES; MALE; MANDIBULAR FRACTURES; MICE; MICE, INBRED C57BL; OSTEONECROSIS; REGENERATION; TIBIAL FRACTURES;

EID: 84857129650     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031771     Document Type: Article

References (48)

1. Kozloff KM, Volakis LI, Marini JC, Caird MS, (2010) Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo. J Bone Miner Res 25 (8): 1748-58.
2. Russell RG, (2006) Bisphosphonates: from bench to bedside. Ann N Y Acad Sci 1068: 367-401.
3. Little DG, McDonald M, Bransford R, Godfrey CB, Amanat N, (2005) Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. J Bone Miner Res 20 (11): 2044-52.
4. Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ, (1997) Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12 (9): 1358-67.
5. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, et al. (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13 (4): 581-9.
6. Durie BG, Katz M, Crowley J, (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (1): 99-102; discussion 99-102.
7. Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, et al. (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23 (6): 826-36.
8. Lesclous P, Abi Najm S, Carrel JP, Baroukh B, Lombardi T, et al. (2009) Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45 (5): 843-52.
9. Noden DM, Trainor PA, (2005) Relations and interactions between cranial mesoderm and neural crest populations. J Anat 207 (5): 575-601.
10. Eames BF, Helms JA, (2004) Conserved molecular program regulating cranial and appendicular skeletogenesis. Dev Dyn 231 (1): 4-13.
11. Eames BF, Sharpe PT, Helms JA, (2004) Hierarchy revealed in the specification of three skeletal fates by Sox9 and Runx2. Dev Biol 274 (1): 188-200.
12. Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, et al. (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 (3): 1055-61.
13. D'Aoust P, McCulloch CA, Tenenbaum HC, Lekic PC, (2000) Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria. Cell Tissue Res 302 (3): 353-63.
14. Ortega C, Montemurro F, Faggiuolo R, Vormola R, Nanni D, et al. (2007) Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Acta Oncol 46 (5): 664-8.
15. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA, (2003) Altered fracture repair in the absence of MMP9. Development 130 (17): 4123-33.
16. Behonick DJ, Xing Z, Lieu S, Buckley JM, Lotz JC, et al. (2007) Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration. PLoS ONE 2 (11): e1150.
17. Lu C, Xing Z, Yu YY, Colnot C, Miclau T, et al. (2010) Recombinant human bone morphogenetic protein-7 enhances fracture healing in an ischemic environment. J Orthop Res 28 (5): 687-96.
18. Lu C, Hansen E, Sapozhnikova A, Hu D, Miclau T, et al. (2008) Effect of age on vascularization during fracture repair. J Orthop Res 26 (10): 1384-9.
19. Lu C, Saless N, Hu D, Wang X, Xing Z, et al. (2011) Mechanical stability affects angiogenesis during early fracture healing. J Orthop Trauma 25 (8): 494-9.
20. Gundersen HJ, Jensen EB, Kieu K, Nielsen J, (1999) The efficiency of systematic sampling in stereology-reconsidered. J Microsc 193 (Pt 3): 199-211.
21. Schionning JD, Larsen JO, (1997) A stereological study of dorsal root ganglion cells and nerve root fibers from rats treated with inorganic mercury. Acta Neuropathol 94 (3): 280-6.
22. Thompson Z, Miclau T, Hu D, Helms JA, (2002) A model for intramembranous ossification during fracture healing. J Orthop Res 20 (5): 1091-8.
23. Probst A, Spiegel HU, (1997) Cellular mechanisms of bone repair. Journal of Investigative Surgery 10 (3): 77-86.
24. Groothuis A, Duda GN, Wilson CJ, Thompson MS, Hunter MR, et al. (2010) Mechanical stimulation of the pro-angiogenic capacity of human fracture haematoma: involvement of VEGF mechano-regulation. Bone 47 (2): 438-44.
25. Boerckel JD, Uhrig BA, Willett NJ, Huebsch N, Guldberg RE, (2011) Mechanical regulation of vascular growth and tissue regeneration in vivo. Proc Natl Acad Sci U S A 108 (37): E674-80.
26. Colnot C, (2009) Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 24 (2): 274-82.
27. Leucht P, Kim JB, Amasha R, James AW, Girod S, et al. (2008) Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 135 (17): 2845-54.
28. Amanat N, McDonald M, Godfrey C, Bilston L, Little D, (2007) Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res 22 (6): 867-76.
29. D'Amelio P, Grimaldi A, Di Bella S, Tamone C, Brianza SZ, et al. (2008) Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women. J Bone Miner Res 23 (3): 373-9.
30. Sudhoff H, Jung JY, Ebmeyer J, Faddis BT, Hildmann H, et al. (2003) Zoledronic acid inhibits osteoclastogenesis in vitro and in a mouse model of inflammatory osteolysis. Ann Otol Rhinol Laryngol 112 (9 Pt 1): 780-6.
31. Kimachi K, Kajiya H, Nakayama S, Ikebe T, Okabe K, (2011) Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. Naunyn Schmiedebergs Arch Pharmacol 383 (3): 297-308.
32. Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IM, Reinheckel T, et al. (2006) Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int 79 (4): 245-54.
33. Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, et al. (2006) Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res 21 (9): 1399-408.
34. Ayala G, Liu C, Nicosia R, Horowitz S, Lackman R, (2000) Microvasculature and VEGF expression in cartilaginous tumors. Human Pathology 31 (3): 341-6.
35. McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, et al. (2008) Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone 43 (4): 653-62.
36. Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, et al. (2010) Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab 28 (2): 165-75.
37. Bellahcene A, Chaplet M, Bonjean K, Castronovo V, (2007) Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells. Endothelium 14 (2): 123-30.
38. Stresing V, Fournier PG, Bellahcene A, Benzaid I, Monkkonen H, et al. (2011) Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. Bone 48 (2): 259-66.
39. Kang JH, Choi NK, Kang SJ, Yang SY, Ko HM, et al. (2010) Alendronate affects cartilage resorption by regulating vascular endothelial growth factor expression in rats. Anat Rec (Hoboken) 293 (5): 786-93.
40. Evans KD, Lau ST, Oberbauer AM, Martin RB, (2003) Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. Bone 32 (3): 268-74.
41. Evans KD, Oberbauer AM, (2009) Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway. Open Orthop J 3: 83-8.
42. Fromigue O, Body JJ, (2002) Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest 25 (6): 539-46.
43. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS, (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25 (18): 4105-15.
44. von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, et al. (2005) Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26 (34): 6941-9.
45. Koch FP, Merkel C, Ziebart T, Smeets R, Walter C, et al. (2010) Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig.
46. Lopez-Jornet P, Camacho-Alonso F, Molina-Minano F, Gomez-Garcia F, Vicente-Ortega V, (2010) An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats. J Oral Pathol Med 39 (9): 697-702.
47. Bi Y, Gao Y, Ehirchiou D, Cao C, Kikuiri T, et al. (2010) Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. Am J Pathol 177 (1): 280-90.
48. Senel FC, Duman MK, Muci E, Cankaya M, Pampu AA, et al. (2010) Jaw bone changes in rats after treatment with zoledronate and pamidronate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109 (3): 385-91.